Evidence map›Paper›PMID 24393425›Full record

ArticleBMC cancer2014

Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas.

Elena Vigliar, Immacolata Cozzolino, Marco Picardi, Anna Lucia Peluso, Laura Virginia Sosa Fernandez, Antonio Vetrani, Gerardo Botti, Fabrizio Pane, Carmine Selleri, Pio Zeppa

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elena Vigliar
Immacolata Cozzolino
Marco Picardi
Anna Lucia Peluso
Laura Virginia Sosa Fernandez
Antonio Vetrani
Gerardo Botti
Fabrizio Pane
Carmine Selleri
Pio ZeppaDepartment of Medicine and Surgery, Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona", Largo città d'Ippocrate n,1, 84131 Salerno, (IT), Italy. pzeppa@unisa.it.
University of Naples Federico II · ITOspedali Riuniti San Giovanni di Dio e Ruggi d'Aragona · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLymph nodal involvement is an important clinical-pathological sign in primary cutaneous lymphoma (PCL), as it marks the transformation/evolution of the disease from localized to systemic; therefore the surveillance of lymph nodes is important in the staging and follow up of PCL. Fine needle cytology (FNC) is widely used in the diagnosis of lymphadenopathies but has rarely been reported in PCL staging and follow-up. In this study an experience on reactive and neoplastic lymphadenopathies arisen in PCL and investigated by FNC, combined to ancillary techniques, is reported.

methodsTwenty-one lymph node FNC from as many PCL patients were retrieved; 17 patients had mycosis fungoides (MF) and 4 a primary cutaneous B-cell lymphoma (PBL). In all cases, rapid on site evaluation (ROSE) was performed and additional passes were used to perform flow cytometry (FC), immunocytochemistry (ICC) and/or polymerase chain reaction (PCR) to assess or rule out a possible clonality of the corresponding cell populations.

resultsFNC combined with FC, ICC, and PCR identified 12 cases of reactive, non specific, hyperplasia (BRH), 4 dermatopathic lymphadenopathy (DL), 4 lymph nodal involvement by MF and 1 lymph nodal involvement by cutaneous B-cell lymphoma.

conclusionsFNC coupled with ancillary techniques is an effective tool to evaluate lymph node status in PCL patients, provided that ROSE and a rational usage of ancillary techniques is performed according to the clinical context and the available material. The method can be reasonably used as first line procedure in PCL staging and follow up, avoiding expensive and often ill tolerated biopsies when not strictly needed.

Indexed as

Biopsy, Fine-NeedleAdultAgedBiomarkers, TumorFemaleFlow CytometryGenes, T-Cell Receptor gammaHumansImmunohistochemistryLymph NodesLymphoma, B-CellMaleMiddle AgedMycosis FungoidesNeoplasm StagingPolymerase Chain ReactionBiomarkers, Tumor

Identifiers

PMID24393425
PMCPMC3890503
OpenAlexW2001538614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.